Literature DB >> 18159536

Where are all the new antibiotics? The new antibiotic paradox.

Jm Conly1, Bl Johnston.   

Abstract

Year:  2005        PMID： 18159536      PMCID： PMC2095020          DOI： 10.1155/2005/892058

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  7 in total

1.  The global impact of drug resistance.

Authors:  David H Howard; R Douglas Scott; Randall Packard; DeAnn Jones
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

Review 2.  Therapeutic challenges posed by bacterial bioterrorism threats.

Authors:  Peter H Gilligan
Journal:  Curr Opin Microbiol       Date:  2002-10       Impact factor: 7.934

3.  The future of rotavirus vaccines: a major setback leads to new opportunities.

Authors:  Roger I Glass; Joseph S Bresee; Umesh D Parashar; Baoming Jiang; Jon Gentsch
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

4.  Trends in antimicrobial drug development: implications for the future.

Authors:  Brad Spellberg; John H Powers; Eric P Brass; Loren G Miller; John E Edwards
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

5.  Bioterrorism in 2001 - How ready are we?

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2001-03

Review 6.  Antimicrobial resistance in Canada.

Authors:  John Conly
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

7.  Trends in infectious diseases mortality in the United States.

Authors:  R W Pinner; S M Teutsch; L Simonsen; L A Klug; J M Graber; M J Clarke; R L Berkelman
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272
  7 in total
  49 in total

Review 1.  Small molecule control of bacterial biofilms.

Authors:  Roberta J Worthington; Justin J Richards; Christian Melander
Journal:  Org Biomol Chem       Date:  2012-10-07       Impact factor: 3.876

2.  A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.

Authors:  Madeline R Galac; Erik Snesrud; Francois Lebreton; Jason Stam; Michael Julius; Ana C Ong; Rosslyn Maybank; Anthony R Jones; Yoon I Kwak; Kate Hinkle; Paige E Waterman; Emil P Lesho; Jason W Bennett; Patrick Mc Gann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling.

Authors:  Yunierkis Pérez-Castillo; Matheus Froeyen; Miguel Angel Cabrera-Pérez; Ann Nowé
Journal:  J Comput Aided Mol Des       Date:  2011-04-23       Impact factor: 3.686

4.  Current state of the art in rapid diagnostics for antimicrobial resistance.

Authors:  Rathina Kumar Shanmugakani; Balaji Srinivasan; Marshall J Glesby; Lars F Westblade; Washington B Cárdenas; Tony Raj; David Erickson; Saurabh Mehta
Journal:  Lab Chip       Date:  2020-07-09       Impact factor: 6.799

5.  Antimicrobial activity and bioactive profiling of heterocytous cyanobacterial strains using MS/MS-based molecular networking.

Authors:  Kumar Saurav; Markéta Macho; Andreja Kust; Kateřina Delawská; Jan Hájek; Pavel Hrouzek
Journal:  Folia Microbiol (Praha)       Date:  2019-08-05       Impact factor: 2.099

6.  Three-dimensional label-free observation of individual bacteria upon antibiotic treatment using optical diffraction tomography.

Authors:  Jeonghun Oh; Jea Sung Ryu; Moosung Lee; Jaehwang Jung; SeungYun Han; Hyun Jung Chung; Yongkeun Park
Journal:  Biomed Opt Express       Date:  2020-02-03       Impact factor: 3.732

7.  Evaluation of Bacterial RNA Polymerase Inhibitors in a Staphylococcus aureus-Based Wound Infection Model in SKH1 Mice.

Authors:  Jörg Haupenthal; Yannik Kautz; Walid A M Elgaher; Linda Pätzold; Teresa Röhrig; Matthias W Laschke; Thomas Tschernig; Anna K H Hirsch; Vadim Molodtsov; Katsuhiko S Murakami; Rolf W Hartmann; Markus Bischoff
Journal:  ACS Infect Dis       Date:  2020-09-21       Impact factor: 5.084

8.  Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae.

Authors:  Roberta J Worthington; Cynthia A Bunders; Catherine S Reed; Christian Melander
Journal:  ACS Med Chem Lett       Date:  2012-02-04       Impact factor: 4.345

Review 9.  Combination approaches to combat multidrug-resistant bacteria.

Authors:  Roberta J Worthington; Christian Melander
Journal:  Trends Biotechnol       Date:  2013-01-18       Impact factor: 19.536

10.  Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature.

Authors:  Enea Salsi; Alexander S Bayden; Francesca Spyrakis; Alessio Amadasi; Barbara Campanini; Stefano Bettati; Tetyana Dodatko; Pietro Cozzini; Glen E Kellogg; Paul F Cook; Steven L Roderick; Andrea Mozzarelli
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.